0 results available. Select is focused ,type to refine list, press Down to open the menu,
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous...
The following section summarizes insights on Cytosorbents Crp's Cash And Short Term Investments:
We've identified the following companies as similar to Cytosorbents Crp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Cash And Short Term Investments in the financials category include:
Cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly li...
Cytosorbents reported cash and short term investments of 5.685 M for the latest quarter ending September 30, 2024 on its balance sheet.
The tables below summarizes Cytosorbents’s Cash And Short Term Investments and common size over the last five years:
Fiscal Year | Cash And Short Term Investments | Assets | % Assets |
---|---|---|---|
2019-12-31 | 12.232 M | 27.383 M | 44.7% |
2020-12-31 | 71.422 M | 89.95 M | 79.4% |
2021-12-31 | 52.138 M | 89.519 M | 58.2% |
2022-12-31 | 22.145 M | 63.232 M | 35.0% |
2023-12-31 | 14.131 M | 53.261 M | 26.5% |
The tables below summarizes Cytosorbents’s Cash And Short Term Investments and common size over the last four quarters:
Quarter Ending | Cash And Short Term Investments | Assets | % Assets |
---|---|---|---|
2023-12-31 | 14.131 M | 53.261 M | 26.5% |
2024-03-31 | 8.608 M | 47.071 M | 18.3% |
2024-06-30 | 8.459 M | 53.427 M | 15.8% |
2024-09-30 | 5.685 M | 47.804 M | 11.9% |
The chart above depicts the distribution of cash and short term investments for companies operating in the Healthcare sector in the Developed economic region. Over 2,480 companies were considered in this analysis, and 2,385 had meaningful values. The average cash and short term investments of companies in the sector is 139.6 M with a standard deviation of 328.1 M.
Cytosorbents Crp's Cash And Short Term Investments of 5.685 M ranks in the 35.4% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,485 |
Included Constituents | 2,385 |
Min | 3.409 K |
Max | 2.915 B |
Median | 16.591 M |
Mean | 139.6 M |
Standard Deviation | 328.1 M |
You can find companies with similar cash and short term investments using this stock screener.